When it comes to the most widely used adjuvant ingredient found within vaccines, aluminum, many questions have yet to be answered, particularly when it comes to where the aluminum goes after injection, an issue known as biopersistence.
One reason this question arises is because a causative role has been established in what’s known as macrophagic myofasciitis (MMF) lesion in patients who have myalgic encephalomyelitis, or brain inflammation. Myalgia, arthralgia, chronic fatigue, cognitive dysfunction, dysautonomia, and autoimmunity have been temporally linked to aluminium adjuvant-containing vaccine administration (Gherardi and Authier, 2003; Authier et al., 2003; Exley et al., 2009; Rosenblum et al., 2011; Santiago et al., 2014; Brinth et al., 2015; Palmieri et al., 2016).
“Evidence that aluminum-coated particles phagocytozed in the injected muscle and its draining lymph nodes can disseminate within phagocytes throughout the body and slowly accumulate in the brain further suggested that alum safety should be evaluated in the long term.” (source)
This study has prompted further research evaluating the potential hazards of injected aluminum, which begs the question, why hasn’t proper evidence and evaluation been published showing that it’s safe to inject aluminum into babies via several vaccines in a short period of time? Aluminum adjuvants may be effective for stimulating an immune response, but to simply presume there are no consequences for doing this, or to not emphasize or even state the adverse effects that have been discovered, is, I would argue, criminally negligent.
Such negligence is not uncommon when dealing with pharmaceutical companies, however. For example, a study published in the British Medical Journal and conducted by researchers at the Nordic Cochrane Center in Copenhagen showed that pharmaceutical companies were not disclosing all information regarding the results of their drug trials.
Examples of such fraud and corruption are endless, and the result of what many have dubbed the “corporatization” of science. Many from within the field have published a lot of work with the intention of creating more awareness about this grim reality.
Dr. Marcia Angell, a physician and longtime Editor-in-Chief of the New England Medical Journal (NEMJ), one of the most prestigious peer-reviewed medical journals in the world, has said that “it is simply no longer possible to believe much of the clinical research that is published, or to rely on the judgment of trusted physicians or authoritative medical guidelines. I take no pleasure in this conclusion, which I reached slowly and reluctantly over my two decades as an editor of The New England Journal of Medicine.” (source)
She is one of many. You can read more about this here: Peer-Reviewed Science Losing Credibility as Large Amounts of Research Shown to Be False
It’s good to see that we are entering a time when these vaccine ingredients aren’t just assumed to be safe, especially aluminum, which had no place on planet Earth until humans made it, and it definitely has no place in the human body. Because vaccines have, historically, been viewed as non-toxic substances, the FDA and vaccine manufactures simply didn’t conduct appropriate toxicity studies to prove the safety of vaccine ingredients, like aluminum. (source)
A study published in BMC Medicine showed that alum-containing vaccines were associated with the appearance of aluminum deposits in distant organs, such as the spleen and brain, and were still detectable one year after injection. The same group from France published another study two years later, emphasizing that there are “several gaps in the knowledge on alum particles, including their exact mechanisms of action, their fate after injection, their systemic dissemination, and their safety on the long-term. Efforts have been done in the last years to develop novel adjuvants, but attempts to seriously examine safety concerns raised by the bio-persistent character and brain accumulation of alum particles have not been made.”
Fast forward to this year, and multiple in vivo studies have been published showing that injected aluminum, and aluminum used as an adjuvant within vaccines, does not come into the same method of excretion as aluminum that accumulates in our body from our food, for example.
Our bodies do a good job at eliminating this type of aluminum, but the same cannot be said of injected aluminum. This is why multiple studies are implicating injected aluminum with multiple neurodegenerative disorders, like autism in the short term, or Alzheimer’s in the long term, because aluminum could be going to the brain and staying there for life.
Apart from observed behavioural abnormalities, the 2017 study showed that the “measurement of cerebral Al (aluminum) revealed a significantly higher Al level in brains from animals injected . . . than in brains from control group.” (source)
What’s also interesting is that there was “no significant increase” detected in the animals that were injected with a higher dose.
It’s concerning, especially because we already know that environmental aluminium has long been suspected to act as a co-factor in several chronic neurological diseases (Van Rensburg et al., 2001; De Sole et al., 2013; Exley 2013, 2014). Please refer to these studies to see the mechanism by which these authors are suggesting aluminum is transported to the brain.